paroxetine has been researched along with epibatidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camarasa, J; Escubedo, E; Garcia-Ratés, S; Pubill, D | 1 |
| Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D | 1 |
2 other study(ies) available for paroxetine and epibatidine
| Article | Year |
|---|---|
3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.
Topics: Aconitine; Animals; Blotting, Western; Brain; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Drug Synergism; Immunoprecipitation; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Nicotinic Agonists; Paroxetine; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Serotonin Plasma Membrane Transport Proteins; Time Factors; Up-Regulation | 2013 |
Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: an autoradiography study.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Bridged Bicyclo Compounds, Heterocyclic; Drug Interactions; Hallucinogens; Iodine Radioisotopes; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nicotinic Agonists; Paroxetine; Protein Binding; Pyridines; Radiography; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Tritium; Up-Regulation | 2014 |